In 2002, Scott Johnson, a former C.E.O. of several Silicon Valley startups who suffers from multiple sclerosis, created the Myelin Repair Foundation, with the goal of facilitating academic research into treatments for the damaged nerves characteristic of patients with the disease.
Some studies have focused on the optical, biochemical, or nerve electrophysiology characteristics of the meridians [ 2– 4].
Patients with carpal tunnel syndrome, a condition of pain or numbing in the wrist caused by a compressed nerve, show characteristic brain activity patterns in their somatosensory cortex, the brain area that processes sensory information.
However, the late developmental period is precisely when anatomical landmarks with known rhombomeric location become more distinct (nerve roots, characteristic nuclei with known neuromeric position, various decussations).
Histopathology again illustrated a plexiform arrangement with the lesion divided into bundles, each of which surrounded a remnant nerve, with characteristic nodularity, fascicles of palisading spindle cells with storiform appearance, and lack of necrosis or myxoid changes.
Finally, multiple schwannomas, hybrid neurofibroma-schwannomas and sometimes neurofibromas in peripheral and cranial nerves are characteristic of schwannomatosis [ 12, 13].
Muscle and nerve diseases produce characteristic changes in the IP that can be distinguished by IP analysis.
Previous mouse models, by contrast, have failed to exhibit this characteristic nerve cell death.
